4//SEC Filing
Virnich Daniel 4
Accession 0001799191-22-000056
CIK 0001799191other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 7:02 PM ET
Size
10.6 KB
Accession
0001799191-22-000056
Insider Transaction Report
Form 4
Virnich Daniel
Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-07$0.86/sh+175,000$150,500→ 448,585 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-12-07−175,000→ 829,609 totalExercise: $0.86Exp: 2030-03-01→ Common Stock (175,000 underlying) - Exercise/Conversion
Common Stock
2022-12-07$0.86/sh+175,000$150,500→ 623,585 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-12-07−175,000→ 654,609 totalExercise: $0.86Exp: 2030-03-01→ Common Stock (175,000 underlying)
Footnotes (2)
- [F1]These options vest monthly for 36 months following November 12, 2021, the date of the closing of the Business Combination.
- [F2]These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of March 1, 2020 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0001891107
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 7:02 PM ET
- Size
- 10.6 KB